385 related articles for article (PubMed ID: 21937093)
1. The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients.
Lawrie AS; Hills J; Longair I; Green L; Gardiner C; Machin SJ; Cohen H
Thromb Res; 2012 Jul; 130(1):110-4. PubMed ID: 21937093
[TBL] [Abstract][Full Text] [Related]
2. Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting.
Sobieraj-Teague M; Daniel D; Farrelly B; Coghlan D; Gallus A
Thromb Res; 2009 Apr; 123(6):909-13. PubMed ID: 19042011
[TBL] [Abstract][Full Text] [Related]
3. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
[TBL] [Abstract][Full Text] [Related]
4. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods.
Gosselin R; Owings JT; White RH; Hutchinson R; Branch J; Mahackian K; Johnston M; Larkin EC
Thromb Haemost; 2000 May; 83(5):698-703. PubMed ID: 10823265
[TBL] [Abstract][Full Text] [Related]
5. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
Choi Q; Kim JE; Hyun J; Han KS; Kim HK
Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
[TBL] [Abstract][Full Text] [Related]
6. Performance of a point-of-care device in determining prothrombin time in an anticoagulation clinic.
Colella MP; Fiusa MM; Orsi FL; de Paula EV; Annichino-Bizzacchi JM
Blood Coagul Fibrinolysis; 2012 Mar; 23(2):172-4. PubMed ID: 22246165
[TBL] [Abstract][Full Text] [Related]
7. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
[TBL] [Abstract][Full Text] [Related]
8. The reliability of point-of-care prothrombin time testing. A comparison of CoaguChek S and XS INR measurements with hospital laboratory monitoring.
Ryan F; O'Shea S; Byrne S
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e26-33. PubMed ID: 19032373
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors.
Spinler SA; Nutescu EA; Smythe MA; Wittkowsky AK
Ann Pharmacother; 2005 Jun; 39(6):1049-55. PubMed ID: 15855245
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin.
Bauman ME; Black KL; Massicotte MP; Bauman ML; Kuhle S; Howlett-Clyne S; Cembrowski GS; Bajzar L
Thromb Haemost; 2008 Jun; 99(6):1097-103. PubMed ID: 18521514
[TBL] [Abstract][Full Text] [Related]
11. Inaccuracy of point-of-care international normalized ratio in rivaroxaban-treated patients.
Baruch L; Sherman O
Ann Pharmacother; 2013 Sep; 47(9):1210-2. PubMed ID: 24259738
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparin may alter point-of-care assay for international normalized ratio.
Phillips EM; Buchan DA; Newman N; Rajan A; Zia S
Pharmacotherapy; 2005 Oct; 25(10):1341-7. PubMed ID: 16185178
[TBL] [Abstract][Full Text] [Related]
13. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
Jonsson M; Hillarp A; Svensson P
Thromb Res; 2004; 114(2):83-9. PubMed ID: 15306149
[TBL] [Abstract][Full Text] [Related]
14. Acceptability of CoaguChek S and CoaguChek XS generated international normalised ratios against a laboratory standard in a paediatric setting.
Williams VK; Griffiths AB
Pathology; 2007 Dec; 39(6):575-9. PubMed ID: 18027261
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzers.
Karon BS; McBane RD; Chaudhry R; Beyer LK; Santrach PJ
Am J Clin Pathol; 2008 Jul; 130(1):88-92. PubMed ID: 18550476
[TBL] [Abstract][Full Text] [Related]
16. International normalized ratio monitoring of vitamin K antagonist therapy: comparative performance of point-of-care and laboratory-derived testing.
Bonar R; Mohammed S; Favaloro EJ
Semin Thromb Hemost; 2015 Apr; 41(3):279-86. PubMed ID: 25839866
[TBL] [Abstract][Full Text] [Related]
17. Importance of device evaluation for point-of-care prothrombin time international normalized ratio testing programs.
McBane RD; Felty CL; Hartgers ML; Chaudhry R; Beyer LK; Santrach PJ
Mayo Clin Proc; 2005 Feb; 80(2):181-6. PubMed ID: 15704772
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of point of care coagulometers compared to reference laboratory measurements in patients on oral anticoagulation therapy.
Dillinger JG; Si Moussi T; Berge N; Bal Dit Sollier C; Henry P; Drouet L
Thromb Res; 2016 Apr; 140():66-72. PubMed ID: 26901852
[TBL] [Abstract][Full Text] [Related]
19. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
[TBL] [Abstract][Full Text] [Related]
20. Feasibility, cost-effectiveness and patients' acceptance of point-of-care INR testing in a hospital-based anticoagulation clinic.
Kong MC; Lim TG; Ng HJ; Chan YH; Lee LH
Ann Hematol; 2008 Nov; 87(11):905-10. PubMed ID: 18604535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
